ETTX - エンタシス・セラピュ―ティクス (Entasis Therapeutics Holdings Inc.) エンタシス・セラピュ―ティクス

 ETTXのチャート


 ETTXの企業情報

symbol ETTx
会社名 Entasis Therapeutics Holdings Inc (エンタシス・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   エンタシス・セラピュ―ティクスは米国のバイオ医薬品事業持株会社。子会社を通じ、多剤耐性グラム陰性菌感染症の治療薬の新規発見、開発および商業化に焦点をあて事業を行う。主に多剤耐性アシネトバクタ―感染症、淋病、複雑性尿路感染症などの治療薬の臨床試験を手掛ける。本社所在地はマサチュ―セッツ州ウォルサム。   Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections).
本社所在地 35 Gatehouse Drive Waltham MA 02451 USA
代表者氏名
代表者役職名
電話番号
設立年月日 42064
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 34人
url www.entasistx.com
nasdaq_url https://www.nasdaq.com/symbol/ettx
adr_tso
EBITDA EBITDA ー
終値(lastsale) 8.31
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 ETTXのテクニカル分析


 ETTXのニュース

   Entasis Therapeutics introduces ETX0462 targeting gram-negative and biothreat pathogens  2021/07/01 12:14:29 Seeking Alpha
   Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug-Resistant Gram-Negative and Biothreat Pathogens  2021/07/01 12:00:00 Intrado Digital Media
WALTHAM, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the presentation of preclinical data on ETX0462, a novel, first-in-class, diazabicyclooctane with antimicrobial activity against multidrug-resistant (MDR) Gram-negative and biothreat pathogens, at the 2021 World Microbe Forum. ETX0462 potentially represents the first new antibiotic class in 35 years to treat MDR Gram-negative and biothreat infections.
   Entasis Therapeutics shares rise after lining up ETX0462 poster presentation  2021/06/18 12:10:51 Seeking Alpha
   Entasis Therapeutics Holdings Inc. Shares Close the Week 20.2% Higher - Weekly Wrap  2021/03/12 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 20.2% higher than it did at the end of last week. The stock is currently up 23.1% year-to-date, up 12.6% over the past 12 months, and down 71.5% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Shares traded as high as $3.14 and as low as $2.54 this week.Shares closed 5e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 16.3% higher than the 10-day average and 6.1% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 137.8% The company's stock price performance over the past 12 months beats the peer average by 9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics Holdings Inc. Shares Close the Week 21.1% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 21.1% lower than it did at the end of last week. The stock is currently up 7.7% year-to-date, down 48.4% over the past 12 months, and down 75.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $3.34 and as low as $2.57 this week.Shares closed 5e+1% below its 52-week high and 7e+1% above its 52-week low.Trading volume this week was 3.3% lower than the 10-day average and 14.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -37.5% The company's stock price performance over the past 12 months lags the peer average by -638.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics introduces ETX0462 targeting gram-negative and biothreat pathogens  2021/07/01 12:14:29 Seeking Alpha
   Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug-Resistant Gram-Negative and Biothreat Pathogens  2021/07/01 12:00:00 Intrado Digital Media
WALTHAM, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the presentation of preclinical data on ETX0462, a novel, first-in-class, diazabicyclooctane with antimicrobial activity against multidrug-resistant (MDR) Gram-negative and biothreat pathogens, at the 2021 World Microbe Forum. ETX0462 potentially represents the first new antibiotic class in 35 years to treat MDR Gram-negative and biothreat infections.
   Entasis Therapeutics shares rise after lining up ETX0462 poster presentation  2021/06/18 12:10:51 Seeking Alpha
   Entasis Therapeutics Holdings Inc. Shares Close the Week 20.2% Higher - Weekly Wrap  2021/03/12 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 20.2% higher than it did at the end of last week. The stock is currently up 23.1% year-to-date, up 12.6% over the past 12 months, and down 71.5% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Shares traded as high as $3.14 and as low as $2.54 this week.Shares closed 5e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 16.3% higher than the 10-day average and 6.1% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 137.8% The company's stock price performance over the past 12 months beats the peer average by 9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics Holdings Inc. Shares Close the Week 21.1% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 21.1% lower than it did at the end of last week. The stock is currently up 7.7% year-to-date, down 48.4% over the past 12 months, and down 75.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $3.34 and as low as $2.57 this week.Shares closed 5e+1% below its 52-week high and 7e+1% above its 52-week low.Trading volume this week was 3.3% lower than the 10-day average and 14.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -37.5% The company's stock price performance over the past 12 months lags the peer average by -638.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics shares rise after lining up ETX0462 poster presentation  2021/06/18 12:10:51 Seeking Alpha
   Entasis Therapeutics Holdings Inc. Shares Close the Week 20.2% Higher - Weekly Wrap  2021/03/12 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 20.2% higher than it did at the end of last week. The stock is currently up 23.1% year-to-date, up 12.6% over the past 12 months, and down 71.5% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Shares traded as high as $3.14 and as low as $2.54 this week.Shares closed 5e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 16.3% higher than the 10-day average and 6.1% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 137.8% The company's stock price performance over the past 12 months beats the peer average by 9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics Holdings Inc. Shares Close the Week 21.1% Lower - Weekly Wrap  2021/02/26 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 21.1% lower than it did at the end of last week. The stock is currently up 7.7% year-to-date, down 48.4% over the past 12 months, and down 75.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Shares traded as high as $3.34 and as low as $2.57 this week.Shares closed 5e+1% below its 52-week high and 7e+1% above its 52-week low.Trading volume this week was 3.3% lower than the 10-day average and 14.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -37.5% The company's stock price performance over the past 12 months lags the peer average by -638.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics Holdings Inc. Shares Close the Day 11.9% Higher - Daily Wrap  2021/01/22 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed today 11.9% higher than it did at the end of yesterday. The stock is currently up 40.5% year-to-date, down 29.8% over the past 12 months, and down 67.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $3.58 and as low as $2.52 this week.Shares closed 4e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 38.5% lower than the 10-day average and 26.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 276.5% The company's stock price performance over the past 12 months lags the peer average by -1003.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Entasis Therapeutics Holdings Inc. Shares Close the Week 31.4% Higher - Weekly Wrap  2021/01/22 22:30:00 Kwhen Finance
Entasis Therapeutics Holdings Inc. shares closed this week 31.4% higher than it did at the end of last week. The stock is currently up 40.5% year-to-date, down 29.8% over the past 12 months, and down 67.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Shares traded as high as $3.58 and as low as $2.52 this week.Shares closed 4e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 38.5% lower than the 10-day average and 26.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at -0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 276.5% The company's stock price performance over the past 12 months lags the peer average by -1003.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (― 米国株 エンタシス・セラピュ―ティクス ETTX Entasis Therapeutics Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)